To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants.
Clinical trial NCT05065463 · TERMINATED
Trial details
- NCT number
- NCT05065463
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-10
- Primary completion
- 2022-11-23
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.